BCB-214

N/A

Report date: 2025/08/12 15:11:10
NME

Base Information

Drug NameBCB-214
Drug Alias NameBCB-214
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCentral Nervous System NeoplasmsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBrainChild Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesBrainChild Bio Inc
Inactive CompaniesN/A
Active IndicationsCentral Nervous System NeoplasmsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A